Jane Street’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$207K Sell
106,134
-35,407
-25% -$72.2K ﹤0.01% 10063
2026
Q1
$341K Sell
141,541
-55,867
-28% -$125K ﹤0.01% 8940
2025
Q4
$395K Buy
197,408
+3,765
+2% +$8.92K ﹤0.01% 8215
2025
Q3
$591K Buy
+193,643
New +$604K ﹤0.01% 7494
2025
Q2
Sell
-15,583
Closed -$23.5K 10381
2025
Q1
$23.5K Buy
+15,583
New +$27.6K ﹤0.01% 9133
2015
Q3
Sell
-31
Closed -$27K 3932
2015
Q2
$27K Buy
+31
New +$36.5K ﹤0.01% 3549
2014
Q3
Sell
-82
Closed -$271K 2858
2014
Q2
$271K Buy
82
+48
+141% +$111K ﹤0.01% 1921
2014
Q1
$73K Buy
+34
New +$81.3K ﹤0.01% 2555

Other funds holding MBOT

Jane Street's MBOT Position: Q2 2026 in Review

Jane Street reduced its Microbot Medical (MBOT) stake by 25% in Q2 2026, selling an estimated $72.2K and leaving 106,134 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #10063.

Jane Street first reported a position in MBOT in Q1 2014 and has held it in 8 quarters since. The position peaked at $591K in Q3 2025. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Jane Street held 106,134 shares of Microbot Medical worth $207K as of Q2 2026.
  • Jane Street sold 35,407 Microbot Medical shares in Q2 2026, an estimated $72.2K.
  • Microbot Medical made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10063 holding.
  • Jane Street first reported a position in Microbot Medical in Q1 2014 and has held it in 8 quarters since.
  • Jane Street's Microbot Medical position peaked at $591K in Q3 2025.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.